DiscoverBizNews RadioFrom $5 to $750 million: LIFE Healthcare's bold gamble pays off with massive return on alzheimer's diagnostic sale
From $5 to $750 million: LIFE Healthcare's bold gamble pays off with massive return on alzheimer's diagnostic sale

From $5 to $750 million: LIFE Healthcare's bold gamble pays off with massive return on alzheimer's diagnostic sale

Update: 2025-01-15
Share

Description

Life Healthcare’s bold $5 acquisition of a pioneering Alzheimer’s diagnostic company has led to a stunning $750 million payoff. CEO Peter Wharton-Hood reflects on the strategic risks and rewards, highlighting the company’s focused future in Southern Africa’s healthcare sector, while navigating challenges like National Health Insurance.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

From $5 to $750 million: LIFE Healthcare's bold gamble pays off with massive return on alzheimer's diagnostic sale

From $5 to $750 million: LIFE Healthcare's bold gamble pays off with massive return on alzheimer's diagnostic sale

BizNews